Patients' experiences of long-acting injectable antipsychotics: a qualitative study

被引:5
|
作者
Chiu, Lin-Ling [1 ]
Liu, Chun-Hao [2 ,3 ]
Chu, Chun-Lin [4 ]
Lin, Huang-Li [2 ]
Lii, Shu-Chung [5 ]
机构
[1] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Child Psychiat, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Taoyuan, Dept Psychiat, Taoyuan, Taiwan
[5] Chang Gung Univ, Coll Med, Humanist & Social Med Div, 259 Wen Hua 1st Rd, Taoyuan 333, Taiwan
关键词
antipsychotics; experience; long-acting injectable; LAI; qualitative research; SCHIZOPHRENIA; INJECTIONS; PROGRAM;
D O I
10.2147/NDT.S206154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In this study, we applied a qualitative approach to explore patients' subjective experiences of long-acting injectable antipsychotics (LAIs). Methods: Patients undergoing psychiatric treatment from the chronic ward or outpatient department of a medical center in northern Taiwan who had experience with LAI treatment were enrolled. Information was obtained through semi-structured in-depth interviews. The interviews were audio-recorded and then translated verbatim, and the data were collected and analyzed concurrently to develop major themes and categories. Result: In total, 14 participants (8 female) were interviewed. In a bio-psycho-social model, the participants used LAIs as a method to become "normal," in order to achieve a balance between the "effects" and "side effects" that may influence their daily lives. Their past experiences constructed their concepts about and expectations regarding LAIs, and their relationships with their family members and co-workers also modeled their experiences. Conclusion: In our study, we sought to understand the experience of LAI in the daily life context of the patients. We attempted to use a bio-psycho-social model to evaluate the subjective experience of the patients; an improved understanding can help mental health specialists gain a closer insight into patient experience.
引用
收藏
页码:1797 / 1804
页数:8
相关论文
共 50 条
  • [21] Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting
    Kishimoto, Taishiro
    Sanghani, Sohag
    Russ, Mark J.
    Marsh, Akeem N.
    Morris, Joshua
    Basu, Suparna
    John, Majnu
    Kane, John M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (03) : 161 - 168
  • [22] Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics
    Petric, Paula Simina
    Teodorescu, Andreea
    Miron, Ana Aliana
    Manea, Mihnea Costin
    Ifteni, Petru
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e219 - e228
  • [23] Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics
    Zhand, Naista
    Labelle, Alain
    Ghanem, Dana
    Gujral, Preet
    Han, Tommy
    Huneault, Gabrielle
    Jain, Gaurav Kumar
    Robertson, Carrie
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (05) : 475 - 479
  • [24] Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan
    Okada, Yusuke
    Inada, Ken
    Akazawa, Manabu
    SCHIZOPHRENIA RESEARCH, 2023, 252 : 300 - 308
  • [25] Comparison of Subjective Experiences between Patients with Schizophrenia and Bipolar Disorder Receiving Long-Acting Injectable Antipsychotics
    Lin, Shih-Ku
    Cnhen, Wen-Yin
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S203 - S203
  • [26] Industry effects on evidence: a case study of long-acting injectable antipsychotics
    Cosgrove, Lisa
    Mintzes, Barbara
    Bursztajn, Harold J.
    D'Ambrozio, Gianna
    Shaughnessy, Allen F.
    ACCOUNTABILITY IN RESEARCH-ETHICS INTEGRITY AND POLICY, 2024, 31 (01): : 2 - 13
  • [27] Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics
    Bonete Llacer, Jose Maria
    Martinez Hortelano, Alicia
    Richart Albelda, Begona
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2019, 23 (03) : 189 - 193
  • [28] Effectiveness of long-acting injectable antipsychotics in patients with bipolar I disorder
    Yen, Y. C.
    Huang, C. Y.
    BIPOLAR DISORDERS, 2014, 16 : 97 - 98
  • [29] Long-Acting Injectable Antipsychotics in the ElderlyGuidelines for Effective Use
    Prakash S. Masand
    Sanjay Gupta
    Drugs & Aging, 2003, 20 : 1099 - 1110
  • [30] Long-Acting Injectable Antipsychotics: An Underutilized Treatment Option
    Heres, Stephan
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1263 - 1265